1. Home
  2. QTTB vs ORIS Comparison

QTTB vs ORIS Comparison

Compare QTTB & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$4.69

Market Cap

44.3M

Sector

Health Care

ML Signal

HOLD

ORIS

Oriental Rise Holdings Limited Ordinary Shares

HOLD

Current Price

$1.20

Market Cap

49.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTTB
ORIS
Founded
2015
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
44.3M
49.0M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
QTTB
ORIS
Price
$4.69
$1.20
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
156.4K
113.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$152.96
Revenue Growth
100.00
N/A
52 Week Low
$1.38
$0.06
52 Week High
$6.37
$2.27

Technical Indicators

Market Signals
Indicator
QTTB
ORIS
Relative Strength Index (RSI) 57.02 51.64
Support Level $3.99 $1.11
Resistance Level $4.36 $1.27
Average True Range (ATR) 0.40 0.13
MACD -0.00 -0.03
Stochastic Oscillator 62.50 28.67

Price Performance

Historical Comparison
QTTB
ORIS

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

Share on Social Networks: